Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease

BACKGROUND: In the Levodopa in EArly Parkinson’s disease (LEAP) study, 445 patients were randomized to levodopa/carbidopa 100/25 mg three times per day for 80 weeks (early-start) or placebo for 40 weeks followed by levodopa/carbidopa 100/25 mg three times per day for 40 weeks (delayed-start). OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Verschuur, Constant V.M., Suwijn, Sven R., de Haan, Rob J., Boel, Judith A., Post, Bart, Bloem, Bas R., van Hilten, Johannes J., van Laar, Teus, Tissingh, Gerrit, Munts, Alexander, Dijkgraaf, Marcel G.W., de Bie, Rob M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661337/
https://www.ncbi.nlm.nih.gov/pubmed/35938258
http://dx.doi.org/10.3233/JPD-223247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661337/
https://www.ncbi.nlm.nih.gov/pubmed/35938258
http://dx.doi.org/10.3233/JPD-223247

Ejemplares similares